The KRASG12C inhibitors in lung cancer therapy

• المؤلفون الرئيسيون: Maciej Jędrak (مؤلف), Karolina Niekurzak (مؤلف), Joanna Kania (مؤلف), Maciej Józefiak (مؤلف), Piotr Sobkiewicz (مؤلف), Krzysztof Kania (مؤلف)
• التنسيق: كتاب
• منشور في: Kazimierz Wielki University, 2023-09-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Introduction: Lung cancer is characterized by the highest mortality among cancers and is the second most frequently diagnosed type of cancer in the world. Targeted therapies are a promising therapeutic option for patients with this disease, however, one of the most common and most malignant mutation...